https://www.who.int/health-topics/drugs-psychoactive
Feb 9, 2025 · The use of psychoactive drugs without medical supervision is associated with significant health risks and can lead to the development of drug use disorders. Drug use
https://www.who.int/our-work/access-to-medicines-and-health-products/who-drug-information
About WHO Drug Information WHO Drug Information is a quarterly journal providing an overview of topics relating to medicines development and regulation which is targeted to a wide
https://www.who.int/zh/news-room/fact-sheets/detail/essential-medicines
Jan 26, 2026 · 基本药物是有效安全地满足人民医疗保健需求的药物。世卫组织根据公共卫生相关性、有关益处和危害的证据并考虑成本、
https://www.who.int/teams/mental-health-and-substance-use/alcohol-drugs-and-addictive-behaviours/drugs-psychoactive
Jan 1, 2015 · Alcohol, Drugs and Addictive Behaviours The Unit works globally to improve health and well-being of populations by articulating, promoting, supporting and monitoring
https://www.who.int/health-topics/medicines
Access to appropriate medications is shown to have substantial impacts on community health and the related economic indicators. Quality-assured, safe and effective medicines, vacci
https://www.who.int/europe/news-room/fact-sheets/item/drugs-(psychoactive)
Apr 13, 2011 · Substitution maintenance therapy with methadone or buprenorphine improves the health and social performance of opioid-dependent people and decreases the use of illi
https://www.who.int/publications/m/item/canada--a-list-of-essential-prescription-drugs-and-related-products-initial-recommendation-2025-(english)
Sep 2, 2025 · Publications of the World Health Organization Home / Publications / Overview / Canada: A List of Essential Prescription Drugs and Related Products-Initial Recommenda
https://www.who.int/publications/i/item/9789240105140
Apr 1, 2025 · This report presents the first World Health Organization (WHO) analysis of antifungal agents in preclinical and clinical development. It covers systemic antifungal d
https://www.who.int/teams/health-product-and-policy-standards/inn/
Our team provides authoritative guidance and standards on quality, safety and efficacy of health products and supports countries to formulate evidence-based policies and ensure goo
https://www.who.int/news/item/01-12-2025-who-issues-global-guideline-on-the-use-of-glp-1-medicines-in-treating-obesity
Dec 1, 2025 · To address the growing global health challenge of obesity, which affects more than 1 billion people, WHO has released its first guideline on the use of Glucagon-Like